These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22145227)

  • 1. [Analysis of the spectrum of bacterial pathogens isolated from patients with complicated skin and soft tissue infections presumably due to grampositive or mixed flora in the countries of the Central and East Europe].
    Khokhlova VN; Karelin AA; Belotserkovskiĭ MV; Stetsiuk OU
    Antibiot Khimioter; 2011; 56(5-6):19-29. PubMed ID: 22145227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Moet GJ; Jones RN; Biedenbach DJ; Stilwell MG; Fritsche TR
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):7-13. PubMed ID: 17059876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of oritavancin against Gram-positive clinical isolates responsible for documented skin and soft-tissue infections in European and US hospitals (2010-13).
    Mendes RE; Farrell DJ; Sader HS; Flamm RK; Jones RN
    J Antimicrob Chemother; 2015 Feb; 70(2):498-504. PubMed ID: 25362568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance mechanisms and epidemiology of multiresistant pathogens in Europe and efficacy of tigecycline in observational studies.
    Heizmann WR; Dupont H; Montravers P; Guirao X; Eckmann C; Bassetti M; García MS; Capparella MR; Simoneau D; Bodmann KF
    J Antimicrob Chemother; 2013 Jul; 68 Suppl 2():ii45-55. PubMed ID: 23772046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
    Jones RN; Mendes RE; Sader HS
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv17-31. PubMed ID: 21115451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inappropriate initial antibiotic treatment for complicated skin and soft tissue infections in hospitalized patients: incidence and associated factors.
    Lipsky BA; Napolitano LM; Moran GJ; Vo L; Nicholson S; Kim M
    Diagn Microbiol Infect Dis; 2014 Jun; 79(2):273-9. PubMed ID: 24661685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The characteristics of Gram-positive bacteria isolated from skin lesions observed in ambulatory patients and the assessment of their susceptibility to antimicrobial drugs].
    Sikora A; Kozioł-Montewka M; Bogut A
    Przegl Lek; 2011; 68(4):196-201. PubMed ID: 21853673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of occurrence and antimicrobial susceptibility of bacterial pathogens associated with skin and soft tissue infections during 1997 from an International Surveillance Programme. SENTRY Participants Group.
    Jones ME; Schmitz FJ; Fluit AC; Acar J; Gupta R; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1999 Jun; 18(6):403-8. PubMed ID: 10442417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
    Cardona AF; Wilson SE
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S69-78. PubMed ID: 26316560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum and potency of ceftaroline tested against leading pathogens causing skin and soft-tissue infections in Europe (2010).
    Farrell DJ; Flamm RK; Sader HS; Jones RN
    Int J Antimicrob Agents; 2013 Apr; 41(4):337-42. PubMed ID: 23466338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2007 May; 58(1):19-26. PubMed ID: 17383139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with expanded anti-Gram-positive activity.
    Biek D; Critchley IA; Riccobene TA; Thye DA
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv9-16. PubMed ID: 21115457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections.
    Sader HS; Mallick R; Kuznik A; Fritsche TR; Jones RN
    Int J Antimicrob Agents; 2007 Dec; 30(6):514-20. PubMed ID: 17959359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres.
    Sader HS; Farrell DJ; Jones RN
    Int J Antimicrob Agents; 2010 Jul; 36(1):28-32. PubMed ID: 20444576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiologic characteristics and antibiotic resistance rates of diabetic foot infections.
    Pontes DG; Silva ITDCE; Fernandes JJ; Monteiro AFG; Gomes PHDS; Ferreira MGM; Lima FG; Correia JO; Santos NJND; Cavalcante LP
    Rev Col Bras Cir; 2020; 47():e20202471. PubMed ID: 32667581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daptomycin: from the mountain to the clinic, with essential help from Francis Tally, MD.
    Eisenstein BI; Oleson FB; Baltz RH
    Clin Infect Dis; 2010 Jan; 50 Suppl 1():S10-5. PubMed ID: 20067387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms].
    Martínez-Gómez Dde A; Ramírez-Almagro C; Campillo-Soto A; Morales-Cuenca G; Pagán-Ortiz J; Aguayo-Albasini JL
    Enferm Infecc Microbiol Clin; 2009 Jun; 27(6):317-21. PubMed ID: 19237227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complicated skin and soft-tissue infections--consider gram-negative pathogens.
    Ruef C
    Infection; 2008 Aug; 36(4):295. PubMed ID: 18663409
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.